Log in to save to my catalogue

Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid ca...

Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8190567

Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers

About this item

Full title

Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers

Publisher

Cham: Springer International Publishing

Journal title

Internal and emergency medicine, 2022-01, Vol.17 (1), p.135-139

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Previous studies reported that COVID-19 patients with cancer had higher rates of severe events such as intensive care unit (ICU) admission, mechanical ventilation (MV) assistance, and death during the COVID-19 course compared to the general population. However, no randomized study compared the clinical course of COVID-19 in patients with hematologi...

Alternative Titles

Full title

Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8190567

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8190567

Other Identifiers

ISSN

1828-0447

E-ISSN

1970-9366

DOI

10.1007/s11739-021-02784-y

How to access this item